X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5459) 5459
Book Chapter (12) 12
Newsletter (3) 3
Magazine Article (2) 2
Publication (2) 2
Book / eBook (1) 1
Book Review (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (3590) 3590
male (3055) 3055
humans (2238) 2238
rats (2113) 2113
pharmacology & pharmacy (1975) 1975
adrenergic uptake inhibitors - pharmacology (1467) 1467
neurosciences (1438) 1438
female (1293) 1293
psychiatry (882) 882
dose-response relationship, drug (783) 783
rats, sprague-dawley (775) 775
mice (708) 708
norepinephrine - metabolism (684) 684
adrenergic uptake inhibitors - therapeutic use (662) 662
adult (661) 661
in vitro techniques (602) 602
rats, wistar (590) 590
serotonin uptake inhibitors - pharmacology (589) 589
norepinephrine (552) 552
noradrenaline (494) 494
physiology (477) 477
serotonin (452) 452
adrenergic alpha-antagonists - pharmacology (445) 445
middle aged (441) 441
time factors (441) 441
dopamine (440) 440
adrenergic beta-antagonists - pharmacology (430) 430
antidepressants (387) 387
clinical neurology (387) 387
adrenergic beta-agonists - pharmacology (377) 377
desipramine - pharmacology (376) 376
adrenergic alpha-agonists - pharmacology (363) 363
isoproterenol - pharmacology (352) 352
serotonin uptake inhibitors - therapeutic use (347) 347
drug interactions (346) 346
treatment outcome (346) 346
double-blind (340) 340
norepinephrine - pharmacology (339) 339
antidepressive agents - pharmacology (334) 334
biochemistry & molecular biology (329) 329
receptors (326) 326
brain (313) 313
rat (313) 313
atomoxetine hydrochloride (309) 309
depression (308) 308
attention deficit disorder with hyperactivity - drug therapy (306) 306
adrenergic uptake inhibitors - adverse effects (301) 301
cells, cultured (291) 291
dopamine - metabolism (291) 291
adolescent (277) 277
serotonin - metabolism (276) 276
research (272) 272
adrenergic uptake inhibitors - administration & dosage (266) 266
cardiac & cardiovascular systems (262) 262
pharmacology/toxicology (261) 261
pharmacology (258) 258
disease models, animal (255) 255
reserpine - pharmacology (255) 255
behavior, animal - drug effects (252) 252
calcium - metabolism (252) 252
aged (250) 250
dopamine uptake inhibitors - pharmacology (250) 250
double-blind method (248) 248
rodents (245) 245
brain - drug effects (244) 244
analysis (241) 241
electric stimulation (241) 241
biomedicine (239) 239
cell biology (235) 235
drug therapy (235) 235
motor activity - drug effects (232) 232
brain - metabolism (231) 231
atomoxetine (230) 230
myocardium - metabolism (227) 227
blood pressure - drug effects (226) 226
adrenergic receptors (224) 224
phosphorylation (221) 221
heart rate - drug effects (220) 220
enzyme inhibitors - pharmacology (219) 219
child (218) 218
medicine & public health (218) 218
in-vivo (217) 217
fluoxetine (212) 212
propranolol - pharmacology (211) 211
receptors, adrenergic, beta - metabolism (210) 210
desipramine (208) 208
prefrontal cortex (208) 208
rat-brain (208) 208
antidepressive agents - therapeutic use (207) 207
inhibition (204) 204
neurology (204) 204
adrenergic beta-antagonists - therapeutic use (196) 196
fluoxetine - pharmacology (196) 196
neurons - drug effects (195) 195
physiological aspects (195) 195
antidepressant (192) 192
cocaine - pharmacology (191) 191
neurons (191) 191
propylamines - therapeutic use (191) 191
catecholamines (188) 188
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5429) 5429
Japanese (37) 37
French (10) 10
German (9) 9
Russian (9) 9
Spanish (8) 8
Hungarian (5) 5
Dutch (2) 2
Polish (2) 2
Arabic (1) 1
Chinese (1) 1
Danish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Psychopharmacology, ISSN 1432-2072, 2011, Volume 219, Issue 2, pp. 313 - 326
... of impulsivity.The effects of selective DA (GBR12909; 2.5–10 mg/kg), NA (atomoxetine; 0.3–3.0 mg/kg) and 5-HT (citalopram; 0.3–3.0 mg/kg) reuptake inhibitors as well as amphetamine... 
Econometric and Statistical Methods: General | Geneeskunde (GENK) | Bescherming en bevordering van de menselijke gezondheid | Medical sciences | Geneeskunde(GENK) | Neurosciences | Impulsivity | Biomedicine | Dopamine | Serotonin | Delayed reward | Pharmacology/Toxicology | Psychiatry | Noradrenaline | Five-choice serial reaction time task | PSYCHIATRY | GLOBAL 5-HT DEPLETION | DEFICIT-HYPERACTIVITY DISORDER | TERM ATOMOXETINE TREATMENT | NEUROSCIENCES | REACTION-TIME-TASK | PREFRONTAL CORTEX | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | RESPONSE-INHIBITION | NUCLEUS-ACCUMBENS CORE | NOREPINEPHRINE TRANSPORTER | PHARMACOLOGY & PHARMACY | D-AMPHETAMINE | Citalopram - pharmacology | Dopamine Uptake Inhibitors - therapeutic use | Male | Dose-Response Relationship, Drug | Time Factors | Reaction Time - drug effects | Atomoxetine Hydrochloride | Serial Learning - drug effects | Animals, Outbred Strains | Choice Behavior - drug effects | Adrenergic Uptake Inhibitors - therapeutic use | Dopamine Uptake Inhibitors - pharmacology | Amphetamine - therapeutic use | Amphetamine - pharmacology | Serotonin Uptake Inhibitors - therapeutic use | Rats | Piperazines - therapeutic use | Piperazines - pharmacology | Animals | Propylamines - therapeutic use | Adrenergic Uptake Inhibitors - pharmacology | Citalopram - therapeutic use | Impulsive Behavior - drug therapy | Propylamines - pharmacology | Serotonin Uptake Inhibitors - pharmacology | Antidepressants | Mental illness | Neurotransmitters | Inhibitor drugs | Response time | Animal behavior | Rodents | Psychopharmacology | Drug abuse | Drug addiction | Mental disorders | Attention deficit hyperactivity disorder | impulsive behavior | Drug delivery | Personality | Reaction time task | Intertrial interval | Amphetamine | Affective disorders | Reinforcement | Norepinephrine | citalopram | Neurotransmission | monoamines | Original Investigation
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 06/2010, Volume 53, Issue 12, pp. 4731 - 4748
...)-4a were synthesized and tested for their abilities to inhibit monoamine uptake and nAChR subtype activities in vitro and acute effects of nicotine in vivo. The 3′,4′-dichlorophenyl [(±)-4n], naphthyl (4r... 
NICOTINIC RECEPTORS | CHEMISTRY, MEDICINAL | DRUG-INTERACTIONS | TRANSPORTERS | TARGETS | ALPHA 6 | BRAIN | BUPROPION HYDROXYLATION | Analgesics - pharmacology | Body Temperature - drug effects | Stereoisomerism | Humans | Bupropion - analogs & derivatives | Motor Activity - drug effects | Male | Nicotinic Antagonists - pharmacology | Structure-Activity Relationship | Serotonin Uptake Inhibitors - chemical synthesis | Nicotine - pharmacology | Adrenergic Uptake Inhibitors - chemistry | Nicotinic Antagonists - chemical synthesis | Analgesics - chemical synthesis | Dopamine Uptake Inhibitors - chemical synthesis | Adrenergic Uptake Inhibitors - chemical synthesis | Nicotinic Agonists - pharmacology | Cell Line | Dopamine Uptake Inhibitors - pharmacology | Bupropion - chemical synthesis | Serotonin Uptake Inhibitors - chemistry | Mice, Inbred ICR | Animals | Bupropion - chemistry | Nicotinic Antagonists - chemistry | Receptors, Nicotinic - physiology | Analgesics - chemistry | Dopamine Uptake Inhibitors - chemistry | Adrenergic Uptake Inhibitors - pharmacology | Bupropion - pharmacology | Mice | Serotonin Uptake Inhibitors - pharmacology | Smoking Cessation | hydroxybupropion | antinociception | hypothermia | nAChR antagonism | norepinephrine uptake | locomotor activity | structure activity relationship | dopamine uptake | bupropion | Nicotine
Journal Article
Journal Article
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 12/2010, Volume 335, Issue 3, pp. 762 - 770
Triple reuptake inhibitors (TRIs) that block the dopamine transporter (DAT), norepinephrine transporter, and serotonin transporter are being developed as a new... 
DEPRESSION | CIRCUITRY | SENSITIVITY | COCAINE | PHARMACOLOGY & PHARMACY | MODEL | DOPAMINE TRANSPORTER | BINDING | BRAIN | BENZTROPINE | Synaptosomes - drug effects | Mice, Inbred A | Neurotransmitter Uptake Inhibitors - therapeutic use | Dopamine Uptake Inhibitors - therapeutic use | Motor Activity - drug effects | Neurotransmitter Uptake Inhibitors - pharmacology | Aza Compounds - adverse effects | Male | Aza Compounds - pharmacology | Synaptosomes - metabolism | Corpus Striatum - cytology | Bridged Bicyclo Compounds, Heterocyclic - adverse effects | Prefrontal Cortex - drug effects | Piperidines - pharmacology | Discrimination (Psychology) | Behavior, Animal - drug effects | Antidepressive Agents - pharmacology | Swimming | Dopamine - metabolism | Locomotion - drug effects | Brain - cytology | Adrenergic Uptake Inhibitors - therapeutic use | Dopamine Uptake Inhibitors - pharmacology | Mice, Inbred C57BL | Serotonin Uptake Inhibitors - therapeutic use | Rats | Hindlimb Suspension | Rats, Sprague-Dawley | Antidepressive Agents - therapeutic use | Cocaine - pharmacology | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Animals | Norepinephrine - metabolism | Depression - prevention & control | Hypothalamus - cytology | Piperidines - therapeutic use | Serotonin - metabolism | Prefrontal Cortex - metabolism | Adrenergic Uptake Inhibitors - pharmacology | Mice | Mice, Inbred BALB C | Serotonin Uptake Inhibitors - pharmacology
Journal Article
Expert Opinion on Therapeutic Patents, ISSN 1354-3776, 02/2014, Volume 24, Issue 2, pp. 131 - 154
Journal Article
Journal Article
The Journal of cell biology, ISSN 1540-8140, 2014, Volume 207, Issue 3, pp. 365 - 374
...–stimulated glucose uptake in brown adipose tissue. We show that β3-adrenoceptors stimulate glucose uptake in brown adipose tissue via a signaling pathway that is comprised of two different parts... 
INSULIN | TRANSPORT | ACTIVATED PROTEIN-KINASE | ADIPOCYTES | STIMULATION | NOREPINEPHRINE | MAMMALIAN PROTEIN | KNOCKOUT | BETA-ADRENOCEPTORS | ADIPOSE-TISSUE | CELL BIOLOGY | Phosphorylation | Adipocytes, Brown - metabolism | Insulin - physiology | TOR Serine-Threonine Kinases - metabolism | Humans | Multipotent Stem Cells - metabolism | Glucose Transporter Type 1 - metabolism | Male | Adrenergic beta-3 Receptor Agonists - pharmacology | Mechanistic Target of Rapamycin Complex 2 | TOR Serine-Threonine Kinases - antagonists & inhibitors | Female | TOR Serine-Threonine Kinases - physiology | Insulin - pharmacology | Cells, Cultured | Morpholines - pharmacology | Pyrimidines - pharmacology | Receptors, Adrenergic, beta-3 - metabolism | Sirolimus - pharmacology | Multiprotein Complexes - physiology | Protein Transport | Animals | Isoproterenol - pharmacology | Glucose - metabolism | Mice | Protein Processing, Post-Translational | Primary Cell Culture | Adipose tissues | Glucose metabolism | Translocation (Genetics) | Genetic research | Genetic aspects | Research | Health aspects | Sirolimus | Multiprotein Complexes | Adipocytes, Brown | Glucose | Isoproterenol | Multipotent Stem Cells | Life Sciences | Pyrimidines | Receptors, Adrenergic, beta-3 | Glucose Transporter Type 1 | Morpholines | Insulin | TOR Serine-Threonine Kinases | Development Biology | Adrenergic beta-3 Receptor Agonists
Journal Article
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 07/2007, Volume 21, Issue 5, pp. 461 - 471
Journal Article